For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.
Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity has been supported by an independent educational grant from Gilead Sciences, Inc.
Disclosure information is available at the beginning of the video presentation.
View all episodes
By PVI, PeerView Institute for Medical Education
3.5
2727 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.
Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity has been supported by an independent educational grant from Gilead Sciences, Inc.
Disclosure information is available at the beginning of the video presentation.
1,868 Listeners
138 Listeners
702 Listeners
499 Listeners
102 Listeners
10 Listeners
5 Listeners
10 Listeners
4 Listeners
2 Listeners
4 Listeners
2 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
2 Listeners
12 Listeners
2 Listeners
4 Listeners
3 Listeners
5 Listeners
288 Listeners
262 Listeners
3,339 Listeners
112,430 Listeners
1,154 Listeners
716 Listeners
50 Listeners
249 Listeners
372 Listeners
315 Listeners